Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Pharmaceutical

Skye Bioscience

Skye Bioscience's headquarters in San Diego, CA, United States

Punit Dhillon

Puneet S. Arora MD FACE

Chris Twitty

Tu Diep

Kaitlyn Arsenault

Eduardo Muñoz

Giovanni Appendino

Margaret Dalesandro

Jeffrey Goldberg

Louis Pasquale

Robert Ritch

Miguel González-Andrades

Paul Grayson

Andy Schwab

Deborah Charych

The Advisory & Clinical Team at Skye Bioscience leverages the expertise of scientific and clinical advisors to guide the development and implementation of cannabinoid-based treatments. They provide strategic insights, oversee clinical trials, and ensure that innovations align with medical standards and address significant unmet medical needs.

Advisory & Clinical Team

The Directors at Skye Bioscience provide strategic oversight and guidance to the company’s operations, focusing on advancing cannabinoid-derived therapies for glaucoma and other unmet medical needs. They ensure alignment with regulatory standards, drive corporate governance, and foster partnerships to enhance research and development initiatives.

Directors

The Leadership Team at Skye Bioscience oversees the strategic direction and operational execution of the company’s mission to develop innovative cannabinoid-based therapies. Comprising key executives such as the CEO and Chief Financial Officer, this team collaborates to secure funding, drive research and development initiatives, and engage with regulatory bodies, ensuring the company meets its goals in addressing significant medical needs.

Leadership Team

Skye Bioscience

Org chart

Board & advisors

Teams

Advisory & Clinical Team

Directors

Leadership Team

Offices

Skye Bioscience

Org chart

Board & advisors

Teams

Advisory & Clinical Team

Directors

Leadership Team

Offices

Related companies